Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Q Laboratories Appoints New Managers | Contract Pharma
Promotions & Moves

Q Laboratories Appoints New Managers

Bird, Smithmeyer, Hubble to head microbiology R&D lab

Q Laboratories has promoted Patrick Bird, M.S. to microbiology research and development lab supervisor. Mr. Bird previously served as microbiology R&D lab project leader. He will coordinate the various projects and functions of the Microbiology R&D Laboratory, including leading studies for vendors seeking AOAC, AFNOR and MicroVal Certification.


 


August Smithmeyer has been promoted to microbiology-pharma lab supervisor at Q Laboratories. Mr. Smithmeyer will oversee the day-to-day operation of the Micro-Pharma lab including maintaining training levels and analyst excellence. He will also be tasked with identifying new avenues of revenue by acquisition of new technology and capabilities or by identifying new potential markets. He previously served as microbiologist and microbiology-pharma lab group leader at Q Laboratories.
 
Also, Holly Hubble has been named microbiology-pharma lab group leader. Ms. Hubble will be responsible for maintaining sample flow through in the lab, assuring turn-around times meet expectations, as well as communicating sample status to clients. She will also assist with workforce scheduling and quality compliance. She moves from her role as microbiologist II to her current group leader position.


Patrick Bird, M.S.

 

August Smithmeyer

Holly Hubble

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters